Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3402)
All Articles published online
|
Aug 21, 2011 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Venegas M, Villanueva RA, González K, Brahm J. IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. World J Gastroenterol 2011; 17(31): 3636-3639 [PMID: 21987611 DOI: 10.3748/wjg.v17.i31.3636] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i31/3636.htm |
| Number | Citing Articles |
| 1 |
J. Angulo, K. Pino, C. Pavez, F. Biel, P. Labbé, J. F. Miquel, A. Soza, M. López‐Lastra. Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells–associated hepatitis C virus RNA in chronically infected patients. Journal of Viral Hepatitis 2013; 20(4): 263 doi: 10.1111/jvh.12076
|
| 2 |
Daniele Blasquez Olmedo, Samária Ali Cader, Luís Cristóvão Porto. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors. Journal of Medical Virology 2015; 87(10): 1702 doi: 10.1002/jmv.24227
|
| 3 |
Abdolvahab Alborzi, Tayebeh Hashempour, Javad Moayedi, Zahra Musavi, Gholamreza Pouladfar, Shahin Merat. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients. Medical Microbiology and Immunology 2017; 206(2): 165 doi: 10.1007/s00430-017-0497-y
|
| 4 |
María A Jiménez-Sousa, Amanda Fernández-Rodríguez, María Guzmán-Fulgencio, Mónica García-Álvarez, Salvador Resino. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Medicine 2013; 11(1) doi: 10.1186/1741-7015-11-6
|
| 5 |
Mauricio Venegas, Jaime Poniachik, Francisco Fuster, Carmen Hurtado, Rodrigo A Villanueva, Javier Brahm. Genotype F of Hepatitis B: Response to Interferon. Antiviral Therapy 2015; 20(4): 453 doi: 10.3851/IMP2886
|
| 6 |
E Cariani, L Roli, G Missale, E Villa, C Ferrari, T Trenti. Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis. The Pharmacogenomics Journal 2016; 16(1): 18 doi: 10.1038/tpj.2015.28
|
| 7 |
Ahmad Ayadi, Amir Hossein Nafari, Fatemeh Sakhaee, Kimia Rajabi, Yaser Ghaderi, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Host genetic factors and clinical parameters influencing the occult hepatitis C virus infection in patients on chronic hemodialysis: Is it still a controversial infection?. Hepatology Research 2019; 49(6): 605 doi: 10.1111/hepr.13325
|
| 8 |
Qaisar Ali, Irfan Kalam, Sajjad Ullah, Arshad Jamal, Muhammad Imran, Shafi Ullah, Khurshid Iqbal, Ahmed B Waqar.
Predictive Value of
IL-28B
rs12979860 Variants for Peg-IFN, Sofosbuvir Plus Ribavirin Treatment of HCV Infection in Pakistani Population
. Personalized Medicine 2018; 15(6): 503 doi: 10.2217/pme-2018-0012
|
| 9 |
Heba M. Gouda, Zainab A. El-Saadany, Neveen B. Foad, Rabab M. Salama. Interleukin 28B Polymorphisms and Therapy Response in Egyptian Hepatitis C Genotype-4 Patients. DNA and Cell Biology 2014; 33(9): 642 doi: 10.1089/dna.2014.2489
|
| 10 |
Yin Mi, Ying Tang Gao, Xiao Lei Jiao, Hua Guo, Tong Liu, Li Jing, Wen Xia Shi, Zhi Du. The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin. Hepatitis Monthly 2014; 14(8) doi: 10.5812/hepatmon.18793
|
| 11 |
Y. Chen, H.‐X. Xu, L.‐J. Wang, X.‐X. Liu, R. I. Mahato, Y.‐R. Zhao. Meta‐analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon‐α and ribavirin. Alimentary Pharmacology & Therapeutics 2012; 36(2): 91 doi: 10.1111/j.1365-2036.2012.05131.x
|
| 12 |
Claudio Torres, Javier Brahm, Mauricio Venegas. Lambda Interferon Serum Levels in Patients with Chronic Hepatitis C Virus Infection According to Their Response to Therapy with Pegylated Interferon and Ribavirin. Journal of Interferon & Cytokine Research 2014; 34(2): 106 doi: 10.1089/jir.2013.0005
|
| 13 |
Samantha J. Griffiths, Cory M. Dunnigan, Clark D. Russell, Jürgen G. Haas. The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases. Journal of Innate Immunity 2015; 7(3): 231 doi: 10.1159/000369902
|
| 14 |
Marina Kawaguchi‐Suzuki, Reginald F. Frye. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2014; 34(2): 185 doi: 10.1002/phar.1349
|
| 15 |
Hao Zheng, Man Li, Bing Chi, Xiao-xue Wu, Jia Wang, Dian-Wu Liu. IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2015; 39(5): 576 doi: 10.1016/j.clinre.2015.01.009
|
| 16 |
Ma. Sara Sixtos-Alonso, Rosalba Avalos-Martinez, Ricardo Sandoval-Salas, Margarita Dehesa-Violante, Ignacio García-Juarez, Alejandro Chávez-Ayala, Aarón Domínguez-López, Florencia Vargas-Vorácková, Liz Toapanta-Yanchapaxi, Luis Manuel Amezcua-Guerra, Misael Uribe, Juan Francisco Sánchez-Ávila. A Genetic Variant in the Interleukin 28B Gene As a Major Predictor for Sustained Virologic Response in Chronic Hepatitis C Virus Infection. Archives of Medical Research 2015; 46(6): 448 doi: 10.1016/j.arcmed.2015.07.001
|
| 17 |
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America. 2017; : 333 doi: 10.1007/978-3-319-54567-7_17
|
| 18 |
Amir Hossein Nafari, Ahmad Ayadi, Zahra Noormohamadi, Fatemeh Sakhaee, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms. Infection, Genetics and Evolution 2020; 79: 104144 doi: 10.1016/j.meegid.2019.104144
|
| 19 |
Yueqiu Luo, Caixia Jin, Zongxin Ling, Xiaozhou Mou, Qiong Zhang, Charlie Xiang. Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis. Gene 2013; 513(2): 292 doi: 10.1016/j.gene.2012.10.030
|
| 20 |
M Asnavandi, M Zargar, F Vaziri, F R Jamnani, S Gharibzadeh, A Fateh, S D Siadat. EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C. Genes & Immunity 2017; 18(3): 144 doi: 10.1038/gene.2017.12
|
| 21 |
Alejandro Soza, Marcelo Lopez-Lastra. IL28B Polymorphisms Among Latin American HCV Patients. Current Hepatitis Reports 2013; 12(4): 276 doi: 10.1007/s11901-013-0182-6
|
| 22 |
Sreedhar Chinnaswamy, Snehajyoti Chatterjee, Ramachandran Boopathi, Shuvolina Mukherjee, Samsiddhi Bhattacharjee, Tapas K. Kundu, Philippe Gallay. A Single Nucleotide Polymorphism Associated with Hepatitis C Virus Infections Located in the Distal Region of the IL28B Promoter Influences NF-κB-Mediated Gene Transcription. PLoS ONE 2013; 8(10): e75495 doi: 10.1371/journal.pone.0075495
|
| 23 |
Naila Shaikh, Ali Muhammad Waryah, Bikha Ram Devrajani, Muhammad Irfan Rajput, Atif Sitwat Hayat, Samiullah Shaikh. IL28Brs12980275 polymorphism shows association with response to treatment in Pakistani patients with Chronic Hepatitis C. Journal of Medical Virology 2015; 87(5): 814 doi: 10.1002/jmv.24100
|
| 24 |
Alessandra Biasiolo, Andrea Martini, Patrizia Pontisso. New biomarkers for clinical management of hepatitis C virus infected patients. World Journal of Clinical Infectious Diseases 2015; 5(4): 59-66 doi: 10.5495/wjcid.v5.i4.59
|
| 25 |
Kyoungsub Song, Chang Han, Srikanta Dash, Luis A Balart, Tong Wu. MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World Journal of Hepatology 2015; 7(3): 498-506 doi: 10.4254/wjh.v7.i3.498
|
| 26 |
Anwar Jamal Khan, Vivek Aanand Saraswat, Prabhat Ranjan, Devendra Parmar, Tajwar Singh Negi, Samir Mohindra. Polymorphism in interferon λ3/interleukin‐28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy. Journal of Medical Virology 2019; 91(4): 659 doi: 10.1002/jmv.25359
|
| 27 |
Samar Samir Youssef, Eman Abd El Razek Abbas, Rana Ahmed Youness, Moustafa Nouh Elemeery, Amal Soliman Nasr, Sameh Seif. PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression. Archives of Physiology and Biochemistry 2022; 128(2): 483 doi: 10.1080/13813455.2019.1694039
|
| 28 |
Tayebeh Hashempour, Behzad Dehghani, Zahra Mousavi, Tahereh Akbari, Zahra Hasanshahi, Javad Moayedi, Maryam Yahaghi, Mohammad Ali Davarpanah. Association of Mutations in the NS5A-PKRBD Region and IFNL4 Genotypes with Hepatitis C Interferon Responsiveness and its Functional and Structural Analysis. Current Proteomics 2021; 18(1): 38 doi: 10.2174/1570164617666200107091124
|
| 29 |
Seyed Hamidreza Monavari, Roohollah Fateh, Farzam Vaziri, Fatemeh Rahimi Jamnani, Enayat Anvari, Farzin Sadeghi, Parviz Afrough, Ava Behrouzi, Fatemeh Sakhaee, Sepideh Meidaninikjeh, Hamidreza Mollaie, Alireza Hadizadeh Tasbiti, Shamsi Yari, Maryam Sadeghi, Abolfazl Fateh, Seyed Davar Siadat. A comparative study of various methods for detection ofIL28Brs12979860 in chronic hepatitis C. Scandinavian Journal of Clinical and Laboratory Investigation 2017; 77(4): 247 doi: 10.1080/00365513.2017.1299207
|
| 30 |
Simone Regina Souza da Silva Conde, Julius Caesar Mendes Soares Monteiro, Bruna Tereza Silva dos Santos, Nathália Karla Fonseca Filgueiras, Pedro Alves de Almeida Lins, Felipe Bonfim Freitas, Ednelza da Silva Graça, Sâmia Demachki, Marialva Tereza Ferreira de Araújo, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. SNP rs8099917 in GeneIL28BMight Be Associated with Risk of Chronic Infection by HCV but Not with Response to Treatment. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/748606
|
| 31 |
Natalia Echeverría, Daniela Chiodi, Pablo López, Adriana Sanchez Ciceron, Jenniffer Angulo, Marcelo López-Lastra, Paola Silvera, Adrian Canavesi, Carla Bianchi, Valentina Colistro, Juan Cristina, Nelia Hernandez, Pilar Moreno. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients. Virology Journal 2018; 15(1) doi: 10.1186/s12985-018-0946-2
|
| 32 |
Amanda A. Silva, Sandra J. Catarino, Angelica B. W. Boldt, Maria Lucia A. Pedroso, Marcia H. Beltrame, Iara J. Messias‐Reason. Effects of MASP2 haplotypes and MASP‐2 levels in hepatitis C‐infected patients. International Journal of Immunogenetics 2018; 45(3): 118 doi: 10.1111/iji.12371
|
| 33 |
Hamid Heidarian Miri, Pooria Fazeli, Mohammad Ali-Hassanzadeh, Peyman Bemani, Dieter Kabelitz, Kurosh Kalantar. Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. Archives of Virology 2021; 166(9): 2469 doi: 10.1007/s00705-021-05141-8
|
| 34 |
Eyal Shteyer, Louis Shekhtman, Tal Zinger, Sheri Harari, Inna Gafanovich, Dana Wolf, Hefziba Ivgi, Rima Barsuk, Ilana Dery, Daniela Armoni, Mila Rivkin, Rahul Pipalia, Michal Cohen Eliav, Yizhak Skorochod, Gabriel S. Breuer, Ran Tur-kaspa, Yonit Weil Wiener, Adi Stern, Scott J. Cotler, Harel Dahari, Yoav Lurie, Eve-Isabelle Pechuer. Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography. PLOS ONE 2019; 14(1): e0210173 doi: 10.1371/journal.pone.0210173
|
| 35 |
Mauricio Venegas, Javier Brahm, Rodrigo A. Villanueva. Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment. Annals of Hepatology 2012; 11(6): 827 doi: 10.1016/S1665-2681(19)31407-3
|